Journal
CELL CYCLE
Volume 4, Issue 9, Pages 1171-1175Publisher
LANDES BIOSCIENCE
DOI: 10.4161/cc.4.9.2001
Keywords
transgenic models; metastasis; prostate cancer; breast cancer; lung cancer; microarray analysis; genomics; stem cells; self-renewal; BMI-1-pathway; survival predictor
Categories
Funding
- NCI NIH HHS [5R01 CA89827] Funding Source: Medline
Ask authors/readers for more resources
Genome-wide expression profiling studies reveal a transcriptionally distinct sub-type of human solid tumors with a marked propensity toward metastatic dissemination, highly malignant clinical behavior, and poor therapy outcome in cancer patients diagnosed with the early stage carcinomas of various origins. This sub-set of tumors acquires full metastatic potential, including an emergence and seeding of potent metastasis precursor cells, early in tumor progression. Collectively, these data suggest an early involvement in development of this transcriptionally defined sub-type of human carcinomas of a highly malignant combination of mutant alleles conferring the proclivity to metastasize and/or an engagement in transformation and tumor progression of stem cells and/or early progenitor cells. Enrichment of primary tumors with normal stem cells increases the likelihood of horizontal genomic transfer ( large-scale transfer of DNA and chromatin) between stem cells and cancer cells via cell fusion and/or uptake of apoptotic bodies and generation of reprogrammed somatic cell hybrids with self-renewing highly malignant phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available